Cell Therapy

News

Gilead combs Shoreline for NK cell therapies in $2.3bn allia...

Gilead Sciences' cell therapy Kite Pharma has bulked up its position in natural killer (NK) cell therapies, pledging up to $2.3 billion for a partnership with Shoreline Bioscience focusing

News

Close Up Of Senior Man Suffering With Parkinsons Diesease

Bayer's two-pronged cell/gene therapy assault on Parkinson's...

Bayer subsidiary BlueRock Therapeutics has dosed the first Parkinson's disease patient in a phase 1 trial of its cell-based therapy DA01, which aims to replenish the neurons lost in people

Views & Analysis

How-cell-and-gene-therapies-are-transforming-the-pace-of-deal-making

New Cell & Gene Therapy Collective seeks to boost UK adoptio...

The UK has been a global leader in introducing cell and gene therapies that can potentially transform the lives of patients with debilitating diseases – but there are still many barriers to

Views & Analysis

Tackling diabetes & ALS with cell therapy

Israeli company Kadimastem is developing regenerative medicine therapies based on differentiated cells derived from human embryonic stem cells to treat diseases such as Amyotrophic lateral

R&D